VTVT: Vtv Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Vtv Therapeutics Inc (VTVT).
$44.04M Market Cap.
VTVT Market Cap. (MRY)
VTVT Shares Outstanding (MRY)
VTVT Assets (MRY)
Total Assets
$38.27M
Total Liabilities
$23.96M
Total Investments
$0
VTVT Income (MRY)
Revenue
$1.02M
Net Income
-$18.46M
Operating Expense
$25.20M
VTVT Cash Flow (MRY)
CF Operations
-$25.31M
CF Investing
$0
CF Financing
$52.61M
VTVT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $38,266,000 (247.30%) | $11,018,000 (-66.85%) | $33,238,000 (30.48%) | $25,474,000 (72.25%) |
Assets Current | $38,113,000 (257.63%) | $10,657,000 (-60.67%) | $27,094,000 (73.45%) | $15,621,000 (116.51%) |
Assets Non-Current | $153,000 (-57.62%) | $361,000 (-94.12%) | $6,144,000 (-37.64%) | $9,853,000 (30.09%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $12,199,000 (149.43%) | -$24,680,000 (-129.80%) | -$10,740,000 (-10.27%) | -$9,740,000 (87.84%) |
Property Plant & Equipment Net | $153,000 (-57.62%) | $361,000 (-35.07%) | $556,000 (-18.24%) | $680,000 (-19.91%) |
Cash & Equivalents | $36,746,000 (289.01%) | $9,446,000 (-22.10%) | $12,126,000 (-9.61%) | $13,415,000 (133.43%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $17,831,000 (94.39%) | $9,173,000 (36.40%) |
Investments Current | $0 (0%) | $0 (0%) | $12,243,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $5,588,000 (-39.08%) | $9,173,000 (36.40%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $102,000 (-41.04%) | $173,000 (203.51%) | $57,000 (-63.92%) |
Trade & Non-Trade Payables | $5,027,000 (-50.92%) | $10,242,000 (40.05%) | $7,313,000 (-8.85%) | $8,023,000 (31.09%) |
Accumulated Retained Earnings (Deficit) | -$299,718,000 (-6.65%) | -$281,042,000 (-5.84%) | -$265,524,000 (-6.71%) | -$248,834,000 (14.21%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $169,000 (-68.05%) | $529,000 (-26.12%) | $716,000 (-23.18%) | $932,000 (1.86%) |
Debt Current | $169,000 (-53.06%) | $360,000 (-4.76%) | $378,000 (-14.09%) | $440,000 (84.10%) |
Debt Non-Current | $0 (0%) | $169,000 (-50.00%) | $338,000 (-31.30%) | $492,000 (-27.22%) |
Total Liabilities | $23,965,000 (-18.95%) | $29,567,000 (7.91%) | $27,399,000 (167.26%) | $10,252,000 (-6.77%) |
Liabilities Current | $5,196,000 (-51.07%) | $10,619,000 (37.77%) | $7,708,000 (-9.30%) | $8,498,000 (32.99%) |
Liabilities Non-Current | $18,769,000 (-0.94%) | $18,948,000 (-3.77%) | $19,691,000 (1022.63%) | $1,754,000 (-61.92%) |
VTVT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $1,017,000 (0%) | $0 (0%) | $2,018,000 (-49.61%) | $4,005,000 (-37.56%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $13,651,000 (14.65%) | $11,907,000 (-2.41%) | $12,201,000 (-1.15%) | $12,343,000 (70.22%) |
Research & Development Expense | $11,546,000 (-15.07%) | $13,595,000 (10.02%) | $12,357,000 (-7.26%) | $13,324,000 (20.96%) |
Operating Expenses | $25,197,000 (-1.20%) | $25,502,000 (3.84%) | $24,558,000 (2.08%) | $24,058,000 (29.79%) |
Interest Expense | $0 (0%) | $13,000 (-13.33%) | $15,000 (25.00%) | $12,000 (-98.27%) |
Income Tax Expense | $100,000 (0%) | $0 (0%) | $200,000 (73.91%) | $115,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$22,705,000 (12.56%) | -$25,966,000 (-3.56%) | -$25,073,000 (-41.41%) | -$17,731,000 (-38.50%) |
Net Income to Non-Controlling Interests | -$4,243,000 (25.77%) | -$5,716,000 (3.27%) | -$5,909,000 (-24.56%) | -$4,744,000 (-10.25%) |
Net Income | -$18,462,000 (8.83%) | -$20,250,000 (-5.67%) | -$19,164,000 (-47.56%) | -$12,987,000 (-52.81%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$18,462,000 (8.83%) | -$20,250,000 (-5.67%) | -$19,164,000 (-47.56%) | -$12,987,000 (-52.81%) |
Weighted Average Shares | $3,189,606 (22.00%) | $2,614,436 (0.00%) | $2,614,436 (16.15%) | $2,250,916 (21.87%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | -$18,362,000 (9.27%) | -$20,237,000 (-6.80%) | -$18,949,000 (-47.35%) | -$12,860,000 (-64.72%) |
Gross Profit | $1,017,000 (0%) | $0 (0%) | $2,018,000 (-49.61%) | $4,005,000 (-37.56%) |
Operating Income | -$24,180,000 (5.18%) | -$25,502,000 (-13.14%) | -$22,540,000 (-12.40%) | -$20,053,000 (-65.43%) |
VTVT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $4,404,000 (21071.43%) | -$21,000 (0%) | $0 (0%) |
Net Cash Flow from Financing | $52,607,000 (338.50%) | $11,997,000 (-18.69%) | $14,754,000 (-45.31%) | $26,976,000 (38.55%) |
Net Cash Flow from Operations | -$25,307,000 (-32.63%) | -$19,081,000 (-19.09%) | -$16,022,000 (17.02%) | -$19,308,000 (-7.27%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $27,300,000 (1118.66%) | -$2,680,000 (-107.91%) | -$1,289,000 (-116.81%) | $7,668,000 (421.63%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $4,404,000 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | -$21,000 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | -$191,000 (-478.79%) | -$33,000 (-3.13%) | -$32,000 (-118.60%) | $172,000 (103.47%) |
Issuance (Purchase) of Equity Shares | $52,798,000 (338.89%) | $12,030,000 (-18.64%) | $14,786,000 (-44.84%) | $26,804,000 (9.74%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $2,757,000 (74.71%) | $1,578,000 (24.06%) | $1,272,000 (-46.01%) | $2,356,000 (133.50%) |
Depreciation Amortization & Accretion | $89,000 (-1.11%) | $90,000 (-2.17%) | $92,000 (3.37%) | $89,000 (-5.32%) |
VTVT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -1815.30% | - | -949.70% (-192.85%) | -324.30% (-144.75%) |
EBITDA Margin | -1796.80% | - | -934.40% (-193.01%) | -318.90% (-165.09%) |
Return on Average Equity (ROAE) | -114.50% (-233.45%) | 85.80% (-50.83%) | 174.50% (354.43%) | 38.40% (197.67%) |
Return on Average Assets (ROAA) | -40.60% (61.30%) | -104.90% (-72.25%) | -60.90% (-11.74%) | -54.50% (36.11%) |
Return on Sales (ROS) | -1805.50% | - | -939.00% (-192.43%) | -321.10% (-163.85%) |
Return on Invested Capital (ROIC) | 356.20% (-63.41%) | 973.60% (534.06%) | -224.30% (1.19%) | -227.00% (-101.16%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -4.32 (-264.44%) | -1.18 (55.44%) | -2.66 (44.66%) | -4.8 (53.54%) |
Price to Sales Ratio (P/S) | 43.31 | - | 34.35 (53.55%) | 22.37 (4.41%) |
Price to Book Ratio (P/B) | 3.61 (396.39%) | -1.22 (81.13%) | -6.45 (29.83%) | -9.2 (-436.01%) |
Debt to Equity Ratio (D/E) | 1.97 (264.02%) | -1.2 (53.04%) | -2.55 (-142.26%) | -1.05 (-668.61%) |
Earnings Per Share (EPS) | -3.2 (67.04%) | -9.71 (2.71%) | -9.98 (-20.39%) | -8.29 (-15.14%) |
Sales Per Share (SPS) | 0.32 (0%) | 0 (0%) | 0.77 (-56.60%) | 1.78 (-48.78%) |
Free Cash Flow Per Share (FCFPS) | -7.93 (-8.71%) | -7.3 (-18.94%) | -6.14 (28.47%) | -8.58 (11.98%) |
Book Value Per Share (BVPS) | 3.83 (140.52%) | -9.44 (-129.80%) | -4.11 (5.06%) | -4.33 (90.02%) |
Tangible Assets Book Value Per Share (TABVPS) | 12 (184.69%) | 4.21 (-66.85%) | 12.71 (12.34%) | 11.32 (41.34%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -1 (66.67%) | -3 (50.00%) | -6 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.15 (86.94%) | -1.13 (61.45%) | -2.92 (47.74%) | -5.59 (68.95%) |
Asset Turnover | 0.02 (0%) | 0 (0%) | 0.06 (-61.90%) | 0.17 (-73.91%) |
Current Ratio | 7.33 (630.58%) | 1 (-71.44%) | 3.52 (91.24%) | 1.84 (62.80%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$25,307,000 (-32.63%) | -$19,081,000 (-18.94%) | -$16,043,000 (16.91%) | -$19,308,000 (-7.27%) |
Enterprise Value (EV) | $2,686,312 (-88.16%) | $22,679,020 (-58.82%) | $55,072,940 (-22.84%) | $71,372,454 (-48.59%) |
Earnings Before Tax (EBT) | -$18,362,000 (9.32%) | -$20,250,000 (-6.78%) | -$18,964,000 (-47.33%) | -$12,872,000 (-51.45%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$18,273,000 (9.30%) | -$20,147,000 (-6.84%) | -$18,857,000 (-47.65%) | -$12,771,000 (-65.58%) |
Invested Capital | -$3,507,000 (58.83%) | -$8,518,000 (-160.33%) | $14,120,000 (214.27%) | $4,493,000 (25.96%) |
Working Capital | $32,917,000 (86523.68%) | $38,000 (-99.80%) | $19,386,000 (172.16%) | $7,123,000 (763.39%) |
Tangible Asset Value | $38,266,000 (247.30%) | $11,018,000 (-66.85%) | $33,238,000 (30.48%) | $25,474,000 (72.25%) |
Market Capitalization | $44,044,312 (46.49%) | $30,066,020 (-56.62%) | $69,313,940 (-22.63%) | $89,586,454 (-34.81%) |
Average Equity | $16,119,500 (168.31%) | -$23,597,000 (-114.87%) | -$10,982,000 (67.55%) | -$33,845,750 (48.49%) |
Average Assets | $45,517,750 (135.86%) | $19,299,000 (-38.70%) | $31,482,000 (32.11%) | $23,830,500 (139.19%) |
Invested Capital Average | -$5,154,250 (-147.98%) | -$2,078,500 (-124.60%) | $8,448,750 (49.12%) | $5,665,750 (14353.46%) |
Shares | 3,189,606 (22.00%) | 2,614,436 (0.00%) | 2,614,436 (16.15%) | 2,250,916 (21.87%) |
